Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2001

View Archived Issues

Licensing opportunity from NIH: novel antitumor macrocyclic lactones

PowderJect's vaccine pipeline continues to advance

Statin-based LFA-1 inhibitor designed at Novartis for use in inflammation, autoimmune diseases

Enhanced insulin sensitivity obtained in insulin-resistant obese rats treated with BIM-23268

Recent advances in the development of selective aggrecanase inhibitors

Fluad significantly better than nonadjuvanted flu vaccine against pandemic flu virus strain

Positive Seroquel data presented at Conference on Bipolar Disorder

Antagonist of hTSH and hTSI engineered in Israel as potential treatment for hyperthyroidism

First evidence that topical antisense drug penetrates psoriatic lesions

Betatropin: a new approach to type 2 diabetes discussed at recent scientific meetings

Novartis sells rights to five CNS products to Mallinckrodt

Drop in disease progression on Casodex reported in prostate cancer trial

Tanabe Seiyaku licenses DDS technologies to aaiPharma

Insulin sensitizer licensed out by Roche to Kowa

Heterocyclic compounds with activity at alpha1-adrenoceptors and several 5-HT receptors

Atridox receives approval in Switzerland

Safe intracerebroventricular doses of huperzine A determined in animals

New salt of carvedilol with improved water solubility

Janssen patents new triazole protein farnesyltransferase inhibitors

Thyroid receptor antagonists and their use disclosed by Karo Bio in recent patent

Two patents cover P2T antagonists discovered at AstraZeneca

Dengue subgenomic replicons available for licensing from NIH

Naftidrofuryl effective and safe in patients with vascular or mixed dementia

Bayer HBV compound available for licensing worldwide

Melatonin has beneficial effects on sleep quality and Hb1Ac in type 2 diabetics

Company Profile: DrugAbuse Sciences

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...